Multiple hormone resistance and alterations of GPCRs signaling

Research output: Contribution to journalArticlepeer-review


Metabolic disorders deriving from the non-responsiveness of target organs to hormones, which manifest clinically similar to the deficiency of a given hormone itself, derive from molecular alterations affecting specific hormone receptors.Pseudohypoparathyroidism (PHP) and related disorders exemplify an unusual form of hormone resistance as the underlying molecular defect is a partial deficiency of the α subunit of the stimulatory G protein (Gsα), a key regulator of cAMP signaling pathway, or, as more recently described, of downstream effector proteins of the same pathway, such as PKA regulatory subunit 1A (R1A) and phosphodyestarase type 4D (PDE4D). In this group of diseases, resistance to hormones such as PTH, TSH, gonadotropins and GHRH may be variably present, so that the clinical and molecular overlap among these different but related disorders represents a challenge for endocrinologists as to differential diagnosis and genetic counseling.This review will describe the presenting features of multiple resistance in PHP and related disorders, focusing on both our current understanding and future challenges.

Original languageEnglish
Pages (from-to)141-154
JournalBest Practice and Research: Clinical Endocrinology and Metabolism
Issue number2
Publication statusPublished - 2018


  • Acrodysostosis (ACRDYS)
  • GNAS
  • Hormone resistance
  • PDE4D
  • Pseudohypoparathyroidism (PHP)

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology


Dive into the research topics of 'Multiple hormone resistance and alterations of GPCRs signaling'. Together they form a unique fingerprint.

Cite this